Welcome to InvestorStemCell Be a part of the Future of Medicine and join the InvestorStemCell Community! InvestorStemCell is the world's only community dedicated to Regenerative Medicine. Get started by signing up!
Volume and share price are at a standstill. Company expects FDA approval. Is the potential trial approval already priced in at this point? Have people who will buy in already bought in or will this guy jolt upwards soon when official thumbs up is given by the FDA?
IMO, it will go up. The price is somewhat priced in but not completely. I would say it could shoot to $3, maybe even high $3's. The trial is worth billions!! but the FDA approval is for the the scaffold device only!.. Of course trials will proceed after this but the biggest thing is when the device has stem cells/biomaterial in it, which is a separate FDA approval. Which cells the company would use is yet to be known.
I picked up 400 shares only at 2.19. I hope for a quick flip then maybe a re-buy after they submit the next step with FDA. Of course there may be others here than can explain more than I can that has been watching or involved in this company a'lot longer. That's my Opinion. Good Luck on your decision.
I was able to double down yesterday. In all, due to the fast pace for a device clinical trials, cash reserves, Mgmt. and BoD I honestly have to say this company is riped for a buy out by big pharm.
I believe the CEO has noted multiple times during the interviews with the News Shows, if he can get approval for the device clinical trials it'll only take 1 yr. + to get it out on the market. Remember they have a collection of product line, scaffold only, scaffold with stem cell and combinations of others. They are going with the scaffold for now as it can probablyl get revenue for their short term and then they'll dovetail into their other clinical trials since it'll take tons of money. I like the business development and potential product to quickly bring in revenue. To be honest it'll jump up to $3 dollars (IMO) after FDA approval then hover for awhile. They have a market value of $141 Million which I honestly think it is align with the market value, if the company had 5 yr+ until their product hits the market then it'll be out of whack. But, with the fast pace of a device clinical trials I really believe it is under valued at the moment.